Home / Ifosfamide / Sweden
SE ATC L01AA06 · updated 2 Nov 2026
Ifosfamide shortage in Sweden
Is there an Ifosfamide shortage in Sweden?
Yes. As of 2 Nov 2026, 3 Ifosfamide products are reported short in Sweden, the first since 31 Jan 2026. The company estimate for the return is 31 Dec 2026. Main reason: not stated.
Also short in United States, Germany, France, Italy, Austria, Belgium, Switzerland, Czechia, Norway, Japan, Australia. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Holoxan Injektionsflaska, 1000 mg | Baxter Medical AB | 31 Jan 2026 | 31 Dec 2026 | Not stated |
| SE | Holoxan Injektionsflaska, 2000 mg | Baxter Medical AB | 31 Jan 2026 | 31 Dec 2026 | Not stated |
| SE | Holoxan Injektionsflaska, 500 mg | Baxter Medical AB | 31 Jan 2026 | 31 Dec 2026 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.